Table 1.
Disease | COVID-19 | Flu | RSV infection | SARS |
---|---|---|---|---|
Viral agent |
SARS-CoV-2 |
Influenza virus |
RSV |
SARS-CoV |
Transmission | Airborne droplet | Airborne droplet | Airborne droplet | Airborne droplet |
Infection period | N/A | fall and winter | winter | Spring |
Basic reproduction number (Ro) | 2–2.5 | 1.7 | 3.5 | 2–5 |
Case fatality rate (CFR) | ~ 7.1%a | 0.05–0.1% | 4.6% | 9.6–11% |
Incubation time | 2–14 daysb | 1–4 days | 4–5 days | 2–7 days |
Hospitalization rate | 20% | 2% | 2.1% | Most cases |
Annual infected (Global) | N/A | ~ 1 billion | 64 million | 8098 (2003) |
COVID-19 Coronavirus disease 2019
SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2
RSV Respiratory syncytial virus
aData: Updated by European Centre for Disease Prevention and Control (ECDC) on May 122 020)
bMedian time (x͂) = 5–6 days